By proceeding, you agree to our Terms of Use and Privacy Policy.
SomaLogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected, diagnosed and managed.
26-27 May 2022
Global Engage is pleased to announce the 5th Global NASH Congress, which will be taking place on the 14th and 15th of March 2022 in London. An increasing number of people are being diagnosed with nonalcoholic fatty liver disease (NAFLD) and nonalcoho
Event Ended
UK
Paid
London
16-17 June 2022
30+ experts from academia and industry will be presenting their current work in Biomarkers, Latest updates on regulatory guidelines and approvals, Cancer biomarker validation for clinical application, Biomarkers and Personalized Medicine, Impact of B
USA
San Diego
03-04 October 2022
Featuring 40+ presentations, the event brings together over 300 attendees from leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development. The Congress inclu
01-02 November 2022
Learn about recent advances in tumour microenvironment research at the basic, translational and clinical application levels, with exploration of the latest biomarker and spatial technologies to better understand the tumour microenvironment, alongside
Germany
Berlin
Hear from and meet with the leading figures in biomarker analysis to explore how companies are innovating in biomarker analysis to accelerate timelines and reduce risk in drug development, with in-depth consideration of the latest multiplexed and cyt
02-03 March 2023
NASH continues to be a huge unmet clinical need globally, and although no therapy has received regulatory approval, there continues to be research advancing our understanding of the disease’s mechanisms.
Hybrid